- Home
- EKSO
as 07-26-2024 4:00pm EST
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
Upcoming Earnings Alert:
Get ready for potential market movements as Ekso Bionics Holdings Inc. EKSO prepares to release earnings report on 29 Jul 2024.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SAN RAFAEL |
| Market Cap: | 18.5M | IPO Year: | N/A |
| Target Price: | $6.25 | AVG Volume (30 days): | 40.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.97 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.62 - $3.13 | Next Earning Date: | 07-29-2024 |
| Revenue: | $17,913,000 | Revenue Growth: | 23.82% |
| Revenue Growth (this year): | 20.23% | Revenue Growth (next year): | 29.07% |
Stock Insider Trading Activity of Ekso Bionics Holdings Inc. (EKSO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lathan Corinna | EKSO | Director | Aug 10 '23 | Buy | $1.25 | 4,201 | $5,251.25 | 138,458 | SEC Form 4 |
| Lathan Corinna | EKSO | Director | Aug 10 '23 | Buy | $0.95 | 5,500 | $5,221.70 | 143,958 | SEC Form 4 |
| Lathan Corinna | EKSO | Director | Aug 10 '23 | Buy | $1.24 | 4,032 | $5,004.52 | 147,990 | SEC Form 4 |
Latest Ekso Bionics Holdings Inc. News
EKSO Breaking Stock News: Dive into EKSO Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
Simply Wall St.
6 days ago
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO): When Will It Breakeven?
Zacks
a month ago
Ekso Bionics' (EKSO) New Partnership to Aid Its Ekso Devices
GlobeNewswire
a month ago
Ekso Bionics Announces Research Partnership with Shepherd Center
GlobeNewswire
a month ago
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors
GuruFocus.com
a month ago
A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
Energy Global
a month ago
ANDRITZ to equip new Silvan hydropower plant in Türkiye
USA TODAY
a month ago
Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
Compare EKSO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EKSO Ekso Bionics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.